Tokyo, Japan

Motoaki Baba

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Sato Pharmaceutical Co., Ltd., Sato Pharmaceutical Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoaki Baba. Retrieved from https://idiyas.com/inventor/motoaki-baba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Kawasaki, JP (2015 - 2016)
  • Tokyo, JP (2016 - 2017)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Motoaki Baba - Innovator in Pharmaceutical Chemistry

Introduction

Motoaki Baba is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of four patents to his name, Baba's work is recognized for its potential impact on health and medicine.

Latest Patents

One of Baba's latest patents involves a difluoromethylene compound that exhibits URAT1 inhibitory activity. This compound serves as an URAT1 inhibitor, a blood uric acid level-reducing agent, and is part of a pharmaceutical composition. The invention specifically relates to a compound represented by a particular formula, which highlights its innovative approach to addressing health issues related to uric acid levels.

Career Highlights

Baba is currently associated with Sato Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to creating effective pharmaceutical solutions that can improve patient outcomes.

Collaborations

Throughout his career, Baba has collaborated with notable colleagues, including Keita Nagai and Koh Nagasawa. These partnerships have contributed to the successful development of his innovative compounds and have fostered a collaborative environment for research.

Conclusion

Motoaki Baba is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His innovative compounds and collaborative efforts reflect his dedication to improving health outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…